Crinetics Pharmaceuticals Inc (CRNX) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Crinetics Pharmaceuticals Inc   (NASDAQ: CRNX)
 

Crinetics Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Crinetics Pharmaceuticals Inc 's inventory turnover ratio sequentially decreased to 0.67 in the second quarter 2026, otherwise the ratio remained above the average, as CRNX's markets remain strong.Crinetics Pharmaceuticals Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 545 days, from 365 days, in the Mar 31 2026 quarter.

Within Healthcare sector Crinetics Pharmaceuticals Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

CRNX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Crinetics Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CRNX Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 0.67 1 2.13 - -
CRNX's Total Ranking # # # # #
Average inventory processing period 547 364 171 - -
Seq. Inventory Growth 13.84 % 51.53 % - - -
Seq. Cost of Sales Growth -23 % -81.41 % - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 



CRNX Company Profile >> Back to CRNX Efficiency Comparisons >> Compare CRNX Inventory Turnover Ratio to its Competitors

Financial Statements
Crinetics Pharmaceuticals Inc 's Inventories $ 3 Millions Visit CRNX's Balance sheet
Crinetics Pharmaceuticals Inc 's Cost of Revenues TTM $ 1 Millions Visit CRNX's Income Statement
What are CRNX's Sales? Visit CRNX's Sales by Segment

Other Inventory Turnover Ratios
Crinetics Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CRNX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CRNX's Competitors
Inventory Turnover Ratio for CRNX's Suppliers
Inventory Turnover Ratio for CRNX's Customers

You may also want to know
CRNX's Sales Growth Rates CRNX's Pe Price to earnings ratio CRNX's Receivables Turnover Ratio CRNX's Stock Quote
CRNX's Net Income Growth Rates CRNX's Ps Price to Sales ratio CRNX's Sales per Employee CRNX's Asset Turnover Ratio
CRNX's Net Margin CRNX's Pb Price to Book ratio CRNX's Financial Strength Ratios CRNX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Penumbra Inc  1.11 $ 483.975  Millions$ 436  Millions
Zimmer Biomet Holdings Inc   1.10 $ 2,563.400  Millions$ 2,322  Millions
Treace Medical Concepts Inc   1.10 $ 42.186  Millions$ 38  Millions
Corcept Therapeutics Inc  1.10 $ 14.085  Millions$ 13  Millions
Zoetis Inc   1.08 $ 2,709.000  Millions$ 2,505  Millions
Acadia Pharmaceuticals Inc   1.07 $ 100.979  Millions$ 94  Millions
Beone Medicines Ltd   1.07 $ 680.530  Millions$ 639  Millions
Bio Green Med Solution Inc   1.07 $ 1.244  Millions$ 1  Millions
Hyperfine Inc   1.06 $ 6.924  Millions$ 7  Millions
Pacira Biosciences inc   1.04 $ 155.154  Millions$ 149  Millions
Humacyte Inc   1.03 $ 12.611  Millions$ 12  Millions
Vertex Pharmaceuticals Inc  1.03 $ 1,762.800  Millions$ 1,711  Millions
Tg Therapeutics Inc   1.03 $ 140.939  Millions$ 137  Millions
Emergent Biosolutions Inc   1.02 $ 339.900  Millions$ 333  Millions
Renovorx Inc   1.01 $ 0.308  Millions$ 0  Millions
Alkermes Plc   1.01 $ 257.490  Millions$ 256  Millions
Rhythm Pharmaceuticals Inc   0.99 $ 26.389  Millions$ 27  Millions
Seer Inc   0.96 $ 7.596  Millions$ 8  Millions
Eli Lilly And Company  0.92 $ 13,225.000  Millions$ 14,312  Millions
Protalix Biotherapeutics inc   0.91 $ 24.832  Millions$ 27  Millions
Igc Pharma Inc   0.90 $ 0.745  Millions$ 1  Millions
Neurocrine Biosciences Inc   0.89 $ 68.600  Millions$ 77  Millions
Butterfly Network Inc   0.88 $ 53.324  Millions$ 60  Millions
Rxsight Inc   0.87 $ 28.855  Millions$ 33  Millions
Maxcyte inc   0.84 $ 6.450  Millions$ 8  Millions
Establishment Labs Holdings Inc   0.83 $ 71.831  Millions$ 86  Millions
Adma Biologics Inc   0.83 $ 179.465  Millions$ 216  Millions
Tonix Pharmaceuticals Holding Corp   0.83 $ 4.706  Millions$ 6  Millions
Petvivo Holdings Inc   0.83 $ 0.390  Millions$ 0  Millions
Profound Medical Corp   0.81 $ 5.385  Millions$ 7  Millions

Date modified: 2026-09-13T23:45:14+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.